Seneca Therapeutics
Blue Bell
About Seneca Therapeutics
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2025)
- Website: senecatherapeutics.com
- Phone: 484-883-9725
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/seneca-therapeutics-19447 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.